271 related articles for article (PubMed ID: 31939162)
1. Amyloid Oligomers, Protofibrils and Fibrils.
Siddiqi MK; Majid N; Malik S; Alam P; Khan RH
Subcell Biochem; 2019; 93():471-503. PubMed ID: 31939162
[TBL] [Abstract][Full Text] [Related]
2. Amyloid cascade in Alzheimer's disease: Recent advances in medicinal chemistry.
Mohamed T; Shakeri A; Rao PP
Eur J Med Chem; 2016 May; 113():258-72. PubMed ID: 26945113
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils.
Siddiqi MK; Malik S; Majid N; Alam P; Khan RH
Adv Protein Chem Struct Biol; 2019; 118():333-369. PubMed ID: 31928731
[TBL] [Abstract][Full Text] [Related]
4. Why are Functional Amyloids Non-Toxic in Humans?
Jackson MP; Hewitt EW
Biomolecules; 2017 Sep; 7(4):. PubMed ID: 28937655
[TBL] [Abstract][Full Text] [Related]
5. Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation.
Zaman M; Khan AN; Wahiduzzaman ; Zakariya SM; Khan RH
Int J Biol Macromol; 2019 Aug; 134():1022-1037. PubMed ID: 31128177
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of amyloid proteins aggregation and their inhibition by antibodies, small molecule inhibitors, nano-particles and nano-bodies.
Salahuddin P; Khan RH; Furkan M; Uversky VN; Islam Z; Fatima MT
Int J Biol Macromol; 2021 Sep; 186():580-590. PubMed ID: 34271045
[TBL] [Abstract][Full Text] [Related]
7. Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation.
Pilkington EH; Lai M; Ge X; Stanley WJ; Wang B; Wang M; Kakinen A; Sani MA; Whittaker MR; Gurzov EN; Ding F; Quinn JF; Davis TP; Ke PC
Biomacromolecules; 2017 Dec; 18(12):4249-4260. PubMed ID: 29035554
[TBL] [Abstract][Full Text] [Related]
8. Role of water in protein folding, oligomerization, amyloidosis and miniprotein.
Vajda T; Perczel A
J Pept Sci; 2014 Oct; 20(10):747-59. PubMed ID: 25098401
[TBL] [Abstract][Full Text] [Related]
9. Pathway Dependence of the Formation and Development of Prefibrillar Aggregates in Insulin B Chain.
Yoshikawa Y; Yuzu K; Yamamoto N; Morishima K; Inoue R; Sugiyama M; Iwasaki T; So M; Goto Y; Tamura A; Chatani E
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807211
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of lysozyme amyloidogenesis by phospholipids. Focus on long-chain dimyristoylphosphocholine.
Ponikova S; Kubackova J; Bednarikova Z; Marek J; Demjen E; Antosova A; Musatov A; Gazova Z
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2934-2943. PubMed ID: 28865760
[TBL] [Abstract][Full Text] [Related]
11. Insulin and Lispro Insulin: What is Common and Different in their Behavior?
Selivanova OM; Suvorina MY; Surin AK; Dovidchenko NV; Galzitskaya OV
Curr Protein Pept Sci; 2017; 18(1):57-64. PubMed ID: 27226198
[TBL] [Abstract][Full Text] [Related]
12. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer.
Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K
Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950
[TBL] [Abstract][Full Text] [Related]
13. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins.
Huang L; Liu X; Cheng B; Huang K
Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529
[TBL] [Abstract][Full Text] [Related]
14. Oligomers, protofibrils and amyloid fibrils from recombinant human lysozyme (rHL): fibrillation process and cytotoxicity evaluation for ARPE-19 cell line.
Ruiz ED; Almada M; Burboa MG; Taboada P; Mosquera V; Valdez MA; Juárez J
Colloids Surf B Biointerfaces; 2015 Feb; 126():335-43. PubMed ID: 25618793
[TBL] [Abstract][Full Text] [Related]
15. Role of oligomers in the amyloidogenesis of primary cutaneous amyloidosis.
Clos AL; Lasagna-Reeves CA; Kelly B; Wagner R; Wilkerson M; Jackson GR; Kayed R
J Am Acad Dermatol; 2011 Nov; 65(5):1023-31. PubMed ID: 21669474
[TBL] [Abstract][Full Text] [Related]
16. Structure of amyloid oligomers and their mechanisms of toxicities: Targeting amyloid oligomers using novel therapeutic approaches.
Salahuddin P; Fatima MT; Abdelhameed AS; Nusrat S; Khan RH
Eur J Med Chem; 2016 May; 114():41-58. PubMed ID: 26974374
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine-Generated Nanostructures Initiate Amyloid Cross-Seeding in Proteins Leading to a Lethal Aggregation Trap.
Anand BG; Prajapati KP; Shekhawat DS; Kar K
Biochemistry; 2018 Sep; 57(35):5202-5209. PubMed ID: 30080038
[TBL] [Abstract][Full Text] [Related]
18. Structure of cytotoxic amyloid oligomers generated during disaggregation.
Kaku T; Ikebukuro K; Tsukakoshi K
J Biochem; 2024 May; 175(6):575-585. PubMed ID: 38430131
[TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.
Lindgren M; Sörgjerd K; Hammarström P
Biophys J; 2005 Jun; 88(6):4200-12. PubMed ID: 15764666
[TBL] [Abstract][Full Text] [Related]
20. Starting at the beginning: endoplasmic reticulum proteostasis and systemic amyloid disease.
Romine IC; Wiseman RL
Biochem J; 2020 May; 477(9):1721-1732. PubMed ID: 32412081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
